Stereotaxis, Inc. Files 8-K Report
Ticker: STXS · Form: 8-K · Filed: May 13, 2024 · CIK: 1289340
| Field | Detail |
|---|---|
| Company | Stereotaxis, Inc. (STXS) |
| Form Type | 8-K |
| Filed Date | May 13, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, financial-reporting, corporate-update
TL;DR
Stereotaxis filed an 8-K on May 13, 2024, covering financial results and other key events.
AI Summary
On May 13, 2024, Stereotaxis, Inc. filed an 8-K report detailing results of operations, other events, and financial statements. The company, incorporated in Delaware with its principal executive offices in St. Louis, Missouri, is involved in the electromedical and electrotherapeutic apparatus industry.
Why It Matters
This filing provides crucial updates on Stereotaxis, Inc.'s financial condition and operational events, which can impact investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing standard corporate information and financial updates, not indicating immediate significant risk.
Key Numbers
- 001-36159 — SEC File Number (Identifies the company's filing with the SEC.)
- 94-3120386 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- Stereotaxis, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- St. Louis, Missouri (location) — Principal Executive Offices
- May 13, 2024 (date) — Date of earliest event reported
FAQ
What specific financial results are detailed in this 8-K filing?
The filing indicates that it covers 'Results of Operations and Financial Condition' but does not provide specific figures within the provided text.
What are the 'Other Events' mentioned in the filing?
The filing lists 'Other Events' as an item information category, but the specific events are not detailed in the provided text.
What industry does Stereotaxis, Inc. operate in?
Stereotaxis, Inc. operates in the ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry, with SIC code 3845.
Where are Stereotaxis, Inc.'s principal executive offices located?
Stereotaxis, Inc.'s principal executive offices are located at 710 North Tucker Boulevard, Suite 110, St. Louis, Missouri 63101.
What is the filing date of this 8-K report?
The report was filed on May 13, 2024.
Filing Stats: 776 words · 3 min read · ~3 pages · Grade level 11.7 · Accepted 2024-05-13 16:10:46
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share STXS NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 46KB
- ex99-1.htm (EX-99.1) — 57KB
- ex99-1_001.jpg (GRAPHIC) — 51KB
- ex99-2.htm (EX-99.2) — 15KB
- ex99-2_001.jpg (GRAPHIC) — 23KB
- 0001493152-24-018881.txt ( ) — 404KB
- stxs-20240513.xsd (EX-101.SCH) — 3KB
- stxs-20240513_lab.xml (EX-101.LAB) — 33KB
- stxs-20240513_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. STEREOTAXIS, INC. Date: May 13, 2024 By: /s/ Kimberly R. Peery Name: Kimberly R. Peery Title: Chief Financial Officer